Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort.

doi:10.1038/s41598-018-29599-w

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort.

Scientific reports - 30 Jul 2018

Qin Tingting, Zhang Yanxiao, Zarins Katie R, Jones Tamara R, Virani Shama, Peterson Lisa A, McHugh Jonathan B, Chepeha Douglas, Wolf Gregory T, Rozek Laura S, Sartor Maureen A

Abstract excerpt

While whole-exome DNA sequencing is the most common technology to study genetic variants in tumors in known exonic regions, RNA-seq is cheaper, covers most of the same exonic regions, and is often more readily available. In this study, we show the utility of mRNA-seq-based variant analysis combined with targeted gene sequencing performed on both tumor and matched blood as an alternative when exome data is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to APOBEC Deaminases
Share to DNA Mismatch Repair

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, Neoplasm

Share to Germ Cells

Share to Michigan

Share to Mutagens

Share to RNA, Neoplasm

Share to Squamous Cell Carcinoma of Head and Neck

Source

Open in PubMed Open full text

Identifiers

PMID: 30061624
DOI: 10.1038/s41598-018-29599-w
PMCID: PMC6065423

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.